Home Fluorides 133775-25-4
133775-25-4,MFCD28902278
Catalog No.:AA0039RO

133775-25-4 | (2R,3R)-2-(2,4-Difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)butane-2,3-diol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$21.00   $15.00
- +
5g
97%
in stock  
$62.00   $43.00
- +
10g
97%
in stock  
$102.00   $71.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0039RO
Chemical Name:
(2R,3R)-2-(2,4-Difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)butane-2,3-diol
CAS Number:
133775-25-4
Molecular Formula:
C12H13F2N3O2
Molecular Weight:
269.2473
MDL Number:
MFCD28902278
SMILES:
Fc1ccc(c(c1)F)[C@]([C@H](O)C)(Cn1cncn1)O
Properties
Computed Properties
 
Complexity:
311  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
4  
XLogP3:
0.4  

Downstream Synthesis Route

[1]ChemicalandPharmaceuticalBulletin,1992,vol.40,p.562-564

[1]BulletinoftheKoreanChemicalSociety,2010,vol.31,p.3467-3470

[2]Patent:WO2005/14583,2005,A1.Locationinpatent:Page/Pagecolumn15

[3]ChemicalandPharmaceuticalBulletin,1993,vol.41,p.1035-1042

[4]ChemicalandPharmaceuticalBulletin,1992,vol.40,p.562-564

[5]BioorganicandMedicinalChemistryLetters,2007,vol.17,p.3486-3490

[6]Patent:EP659751,1995,A1

[1]BioorganicandMedicinalChemistryLetters,2007,vol.17,p.3486-3490

[2]ChemicalandPharmaceuticalBulletin,1993,vol.41,p.1035-1042

[3]ChemicalandPharmaceuticalBulletin,1993,vol.41,p.1035-1042

[4]Patent:WO2005/14583,2005,A1.Locationinpatent:Page/Pagecolumn14

[1]BulletinoftheKoreanChemicalSociety,2010,vol.31,p.3467-3470

[2]TetrahedronLetters,1996,vol.37,p.611-614

[3]OrganicProcessResearchandDevelopment,2009,vol.13,p.716-728

[1]Park,JoonSeok;Yu,KyungA;Kang,TaeHee;Kim,Sunghoon;Suh,Young-Ger[BioorganicandMedicinalChemistryLetters,2007,vol.17,#12,p.3486-3490]

[2]Gala,Dinesh;DiBenedetto,DonaldJ.;Clark,JonE.;Murphy,BruceL.;Schumacher,DorisP.;Steinman,Martin[TetrahedronLetters,1996,vol.37,#5,p.611-614]

[3]Tasaka;Tamura;Matsushita;Teranishi;Hayashi;Okonogi;Itoh[ChemicalandPharmaceuticalBulletin,1993,vol.41,#6,p.1035-1042]

[4]Na,YoungMin[BulletinoftheKoreanChemicalSociety,2010,vol.31,#11,p.3467-3470]

[5]CurrentPatentAssignee:NANTONGNUOTAIBIOLOGICALPHARMACEUTICAL-CN105367556,2016,A

[6]CurrentPatentAssignee:SECONDMILITARYMEDICALUNIVERSITY-CN110845486,2020,A

[7]CurrentPatentAssignee:SECONDMILITARYMEDICALUNIVERSITY-CN111018839,2020,A

[8]CurrentPatentAssignee:DAEBONGLSLTD-KR2021/36552,2021,A

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:133775-25-4 Molecular Formula|133775-25-4 MDL|133775-25-4 SMILES|133775-25-4 (2R,3R)-2-(2,4-Difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)butane-2,3-diol